Clinical Trials in Hungary

• A Study of Disitamab Vedotin Alone and with Pembrolizumab in Urothelial Cancer That Expresses HER2 Not authorised
  2022-500030-28-00 Phase II Urothelial carcinoma Seagen Inc.
• A Parallel-group (2-Arm), Randomized, Double-blind, 12-week Trial to Evaluate the Efficacy and Safety of MC2-25 Cream and MC2-25 Vehicle in… Not authorised
  2022-500044-38-00 Phase II Chronic Kidney Disease associated Pruritus Mc2 Therapeutics Limited
• An European multinational study of a personalized approach of human albumin administration in patients with cirrhosis of the liver and compl… Not authorised
  2022-501006-34-00 Phase III Liver cirrhosis European Foundation For The Study Of Chronic Liver Failure; Odense University Ho…
• A phase III, randomised, double-blind, multicentre study comparing the efficacy, safety, and immunogenicity of proposed tocilizumab biosimil… Not authorised
  2022-501361-44-00 Phase III Adult patients of either gender with active moderate to seve… Dr. Reddy's Laboratories Limited
• Phase 3 Study Assessing Rocatinlimab (AMG 451) in Adolescent Subjects With Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Orbit) Not authorised
  2022-501535-16-00 Phase III Atopic Dermatitis (AD) Amgen Inc.
• Efepoetin alfa for treatment of anemia in chronic kidney disease on dialysis Not authorised
  2023-503634-50-00 Phase III Anemia in patients with chronic kidney disease on dialysis Genexine Inc.
• A one-year study to assess if Xanomeline/Trospium (XT) can improve cognitive function in adults living with schizophrenia. Not authorised
  2025-523060-20-00 Phase III Schizophrenia European Group for Research in Schizophrenia Stichting
• A randomized, double-blind, placebo-controlled multicenter study to evaluate the effect of inclisiran on preventing major adverse cardiovasc… Unknown
  2022-502779-40-99 Phase III Primary prevention of atherosclerotic cardiovascular disease… Novartis Pharma AG
• A clinical study of MK-7240 for the treatment of ulcerative colitis (MK-7240-001) Unknown
  2025-523766-25-00 Phase III Ulcerative colitis Merck Sharp & Dohme LLC
• Individualized everolimus therapy in metastatic breast cancer Pending
  2023-505590-33-06 Phase II metastatic breast cancer Orszagos Onkologiai Intezet
• Long-term Follow-Up Study of RGX-314 and Fellow Eye Substudy Pending
  2023-505750-17-00 Phase II Neovascular age-related macular degeneration AbbVie Deutschland GmbH & Co. KG
• A Study to Learn About the Study Medicine Called Aztreonam-Avibactam in Neonates and Infants Less Than 9 Months of Age With Suspected or Con… Pending
  2023-507757-15-01 Phase II Sepsis Pfizer Inc.
• DALY II USA/MB-CART2019.1 for DLBCL Pending
  2023-508508-39-01 Phase II Relapsed/refractory diffuse large B cell lymphoma (R-R DLBCL… Miltenyi Biomedicine GmbH
• A research study on how well cagrilintide and CagriSema work in children and adolescents with excess body weight Pending
  2023-509176-42-00 Phase III/IV Obesity and T2D Novo Nordisk A/S
• Normal saline versus lactated Ringer’s solution for fluid administration in acute pancreatitis, an open-label multicenter randomized control… Pending
  2024-511229-79-00 Phase IV Acute Pancreatitis Semmelweis University
• Brain cancer and changes in immune system Pending
  2024-512136-30-00 Phase IV Glioblastoma multiforme Orszagos Onkologiai Intezet
• A trial to learn how well Dato-DXd and rilvegostomig work and how safe they are in participants with stage I adenocarcinoma non-small cell l… Pending
  2024-512195-35-00 Phase III Stage I adenocarcinoma non-small cell lung cancer (NSCLC) wi… AstraZeneca AB
• ALLIC 2022 international clinical investigation for advanced management of childhood acute lymphoblastic leukemia Pending
  2024-513824-41-00 Phase IV Childhood non-mature-B Acute Lymphoblastic Leukemia Semmelweis University
• Measuring of the duration of action of different doses of rocuronium-induced neuromuscular block in infants during surgical treatment of cra… Pending
  2024-515545-41-00 Phase IV a prospective, case-controlled study University Of Debrecen
• Study of Intravenous ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibros… Pending
  2024-518013-25-00 Phase II Idiopathic Pulmonary Fibrosis AbbVie Deutschland GmbH & Co. KG
• Comparing the efficacy and safety of extended (3 h) and intermittent infusion (0.5 h) of beta-lactams (cefepime, ceftriaxone, meropenem, pip… Pending
  2024-518115-19-02 Phase IV suspected or proven infection Semmelweis University
• A phase 2 study of ianalumab in adults with primary Immune Thrombocytopenia (ITP) and Warm-antibody Autoimmune Hemolytic Anemia (wAIHA) who … Pending
  2024-518231-11-00 Phase II Immune thrombocytopenia (ITP) Warm autoimmune hemolytic ane… Novartis Pharma AG
• Study to Investigate the Efficacy, Safety, and Tolerability of Intravenous Gammagard Liquid (Immune Globulin Infusion, 10%) for Primary Infe… Pending
  2024-518420-80-00 Phase III Primary infection prophylaxis for secondary immunodeficiency… Takeda Development Center Americas Inc.
• Dose-ranging study evaluating the efficacy and safety of EVO756 in adults with Chronic Spontaneous Urticaria. Pending
  2024-518786-10-01 Phase II Moderate to Severe Chronic Spontaneous Urticaria Evommune Inc.

Showing 1–24 of 1,245 trials